Drug recall · February 27, 2019
Divalproex Sodium Extended-release Tablets recall
Why: Failed Dissolution Specifications: Out of specification results observed for high dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01
- Lots / codes
Lot #: C802676, Exp 03/20
- Quantity
- 10,656 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- January 31, 2019 · Voluntary: Firm initiated
- Classified
- February 15, 2019
- Reported
- February 27, 2019
- Ended
- February 14, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valproate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.